If we combine the results of previous cohort studies across the spectrum of CKD [49–53], it seems that the association between FGF23 and mortality persists during the predialysis period, starts to be progressively attenuated after initiation of dialysis, almost disappears during long-term dialysis, and then resurges after kidney transplantation. The gene discussed is FGF23; the disease is chronic kidney disease.